RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma

Overview

Journal J Clin Transl Hepatol

Specialty Gastroenterology

Date 2023 Jan 16

PMID 36643034

Authors

Han Zhuo

Chen Wu

Junwei Tang

Feihong Zhang

Zhenggang Xu

Dongwei Sun

Yue Teng

Zhongming Tan

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Chronic hepatitis caused by hepatitis B virus (HBV) infection is a leading cause of hepatocellular carcinoma (HCC). We investigated the roles of oncogenic HBV infection-associated long noncoding RNAs in HCC.

Methods: Bioinformatics analysis of data from the Cancer Genome Atlas (TCGA) was performed to screen potential oncogenic HBV-related lncRNAs. Next, we assessed their expression in clinical samples and investigated their correlation with clinical characteristics. The detailed oncogenic effects were analyzed by performing and studies.

Results: RP11-40C6.2, an HBV infection-related lncRNA, was identified by analysis of the TCGA-Liver Hepatocellular Carcinoma database. Gene Set Enrichment Analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of differentially expressed genes revealed a strong association of RP11-40C6.2 with the Hippo signaling pathway. RP11-40C6.2 was overexpressed in HCC patients with HBV infection compared to those without HBV infection. RP11-40C6.2 transcription showed a positive association with HBV-X protein (HBx), but not HBV core protein (HBc) expression, both of which are carcinogenic proteins. Luciferase gene reporter and ChIP assays revealed that YAP1/TAZ/TEADs complex enhanced RP11-40C6.2 transcription by binding to its promoter area. RP11-40C6.2 showed oncogenic characteristics in HCC cell lines and in animal models that were mediated via activation of YAP1. ubiquitylation assay revealed that RP11-40C6.2 can promote the stabilization of YAP1 by stopping phosphorylation at its s127 residue and further stopping its degradation through binding to 14-3-3.

Conclusions: RP11-40C6.2 is an HBV infection-related lncRNA that exerts its oncogenic effects by targeting the Hippo signaling pathway.

References

Dey A, Varelas X, Guan K . Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 2020; 19(7):480-494. PMC: 7880238. DOI: 10.1038/s41573-020-0070-z. View

Chung T, Lee Y, Kim C . Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J. 2004; 18(10):1123-5. DOI: 10.1096/fj.03-1429fje. View

Du J, Liang X, Liu Y, Qu Z, Gao L, Han L . Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression. Cell Death Differ. 2008; 16(2):219-29. DOI: 10.1038/cdd.2008.144. View

Mak L, Wong D, Pollicino T, Raimondo G, Hollinger F, Yuen M . Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020; 73(4):952-964. DOI: 10.1016/j.jhep.2020.05.042. View

Papatheodoridis G, Chan H, Hansen B, Janssen H, Lampertico P . Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol. 2015; 62(4):956-67. DOI: 10.1016/j.jhep.2015.01.002. View

Moya I, Castaldo S, Van den Mooter L, Soheily S, Sansores-Garcia L, Jacobs J . Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019; 366(6468):1029-1034. DOI: 10.1126/science.aaw9886. View

Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B . LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells. Nat Commun. 2016; 7:13608. PMC: 5146280. DOI: 10.1038/ncomms13608. View

Cheng S, Hu J, Ren J, Yu H, Zhong S, Wong V . Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx. J Hepatol. 2020; 74(3):522-534. DOI: 10.1016/j.jhep.2020.09.019. View

Levrero M, Zucman-Rossi J . Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016; 64(1 Suppl):S84-S101. DOI: 10.1016/j.jhep.2016.02.021. View

10.

Arbuthnot P, Capovilla A, Kew M . Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol. 2000; 15(4):357-68. DOI: 10.1046/j.1440-1746.2000.02069.x. View

11.

Zhang T, Zhang J, You X, Liu Q, DU Y, Gao Y . Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology. 2012; 56(6):2051-9. DOI: 10.1002/hep.25899. View

12.

Li C, Wang S, Xing Z, Lin A, Liang K, Song J . A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis. Nat Cell Biol. 2017; 19(2):106-119. PMC: 5336186. DOI: 10.1038/ncb3464. View

13.

Slagle B, Bouchard M . Hepatitis B Virus X and Regulation of Viral Gene Expression. Cold Spring Harb Perspect Med. 2016; 6(3):a021402. PMC: 4772081. DOI: 10.1101/cshperspect.a021402. View

14.

Ueda H, Ullrich S, Gangemi J, Kappel C, Ngo L, Feitelson M . Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet. 1995; 9(1):41-7. DOI: 10.1038/ng0195-41. View

15.

Cromlish J . Hepatitis B virus-induced hepatocellular carcinoma: possible roles for HBx. Trends Microbiol. 1996; 4(7):270-4. DOI: 10.1016/0966-842x(96)10046-9. View

16.

Caselmann W . Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. J Hepatol. 1995; 22(1 Suppl):34-7. View

17.

Huang P, Xu Q, Yan Y, Lu Y, Hu Z, Ou B . HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis. Oncogene. 2020; 39(18):3774-3789. DOI: 10.1038/s41388-020-1254-z. View

18.

Luo M, Meng Z, Moroishi T, Lin K, Shen G, Mo F . Heat stress activates YAP/TAZ to induce the heat shock transcriptome. Nat Cell Biol. 2020; 22(12):1447-1459. PMC: 7757600. DOI: 10.1038/s41556-020-00602-9. View

19.

Salerno D, Chiodo L, Alfano V, Floriot O, Cottone G, Paturel A . Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription. Gut. 2020; 69(11):2016-2024. PMC: 7569396. DOI: 10.1136/gutjnl-2019-319637. View

20.

Kann M, Lu X, Gerlich W . Recent studies on replication of hepatitis B virus. J Hepatol. 1995; 22(1 Suppl):9-13. View